NCT05977023View on ClinicalTrials.gov

NMDA Receptor Modulation for the Treatment of Bipolar I Disorder

PHASE2RecruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

October 4, 2023

Primary Completion Date

November 30, 2027

Study Completion Date

December 31, 2027

Conditions
Bipolar I Disorder
Interventions
DRUG

NMDAE

Use of an NMDA enhancer for the treatment of bipolar depression

DRUG

Placebo Cap

Use of placebo as a comparator.

Trial Locations (1)

Unknown

RECRUITING

Department of Psychiatry, China Medical University Hospital, Taichung

All Listed Sponsors
collaborator

National Science and Technology Council

FED

lead

China Medical University Hospital

OTHER